Incomplete stent apposition after coronary stent implantation: myth or reality?
Rathore
Sudhir
S
Department of Cardiology, Toyohashi Heart Center, Oyama-cho, Toyohashi, Japan. sudhirrathore@hotmail.com
Terashima
Mitsuyasu
M
Habara
M
M
Kinoshita
Yoshihisa
Y
Nasu
Kenya
K
Katoh
Osamu
O
Suzuki
Takahiko
T
D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use; D016001:Confidence Intervals; D003324:Coronary Artery Disease / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000628:therapy*; D054855:Drug-Eluting Stents; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D015994:Incidence; D016017:Odds Ratio; D017239:Paclitaxel / Q000627:therapeutic use; D012307:Risk Factors; D020123:Sirolimus / Q000627:therapeutic use; D041623:Tomography, Optical Coherence; D018084:Ultrasonography, Interventional
D000972:Antineoplastic Agents, Phytogenic; D007166:Immunosuppressive Agents; D017239:Paclitaxel; D020123:Sirolimus